期刊文献+

神经连接蛋白1与神经突触及认知功能障碍的关系 被引量:4

The relationship of Neuroligin1,synapses and cognitive dysfunction
下载PDF
导出
摘要 大脑信息处理及传输过程需要神经突触的参与,而突触间的特殊细胞黏附分子对神经突触的形成、成熟及功能维持具有重要作用。其中神经连接蛋白1(neuroligin1,NL1)是位于兴奋性突触后膜的细胞黏附分子。NL1通过与神经轴突蛋白1(neurexin1,NRXN1)等分子相互作用,参与突触的发生发展,与突触的可塑性及功能相关。NL1敲除或过表达均可损伤学习记忆功能,提示NL1参与认知功能障碍相关的一些神经精神疾病的病理生理机制。因此,研究NL1的作用可进一步完善认知障碍的发生发展机制,并为认知障碍相关性疾病的防治提供新思路。 All information processing and transmission in the brain involves synapses, the synaptic cell adhesion molecules play an important role in the formation, maturation and maintenance of synapses. Neuroliginl ( NL1) is excitatory postsynaptic transmembrane cell adhesion molecules. The interaction between NL1 and other molecules, such as Neurexinl (NRXN1) , involves in the formation, plasticity and function of synapses. NL1 knockout or overexpression displayed impairment in learning and memory, thus suggesting that NL1 participates in the pathophysiology of neuropsychiatric disease with cognitive dysfunction. Therefore, study of NL1 will open up new avenues to understand pathogenesis of cognitive dysfunction, and may provide a novel insight into prevention and treatment of cognitive dysfunction-associated diseases.
出处 《医学研究生学报》 CAS 北大核心 2016年第10期1097-1100,共4页 Journal of Medical Postgraduates
基金 国家自然科学基金(81471105)
关键词 神经突触 神经连接蛋白1 神经轴突蛋白1 认知功能障碍 Synapses Neuroliginl Neurexinl Cognitive dysfunction
  • 相关文献

参考文献3

二级参考文献75

  • 1黄芳华.治疗老年性痴呆中药的药效学研究评价探讨[J].中国中医基础医学杂志,2006,12(9):701-703. 被引量:5
  • 2杨正钦,杨素芬,杨俊卿,周岐新,李少林.Protective Effects and Mechanism of Total Coptis Alkaloids on Aβ_(25-35) Induced Learning and Memory Dysfunction in Rats[J].Chinese Journal of Integrative Medicine,2007,13(1):50-54. 被引量:10
  • 3罗焕敏,翁文.老年性痴呆动物模型的制作与选择[J].中华老年多器官疾病杂志,2007,6(1):12-16. 被引量:8
  • 4Jack CR Jr, Knopman DS, Jagust WJ, et al. Tracking patho- physiological processes in Alzheimer's disease: an updated hypo- thetical modal of dynamic biomarkers[J]. Lancet Neurol, 2013, 12(2) : 207-216.
  • 5Villemagne VL, Burnham S, Bourgeat P, et al. Amyloid beta deposition, neurodegeneration and cognitive decline in sporadic Alzheimer's disease: a prospective cohort study [J]. Lancet Neurol, 2013, 12(4): 357-367.
  • 6Hampel H, Frank R, Broich K, et al. Biomarkers for Alzheimer' s disease: academic, industry and regulatory perspectives [ J]. Nat Rev Drug Discov, 2010, 9(7) : 560-574.
  • 7Sperling RA, Jack CR Jr, Aisen PS. Testing the right target and right drug at the right stage [ J ]. Sci Transl Med, 2011, 3 (111): 111 end3.
  • 8McKhann G, Drachman D, Folstein M, et al. Clinical diagnosis of Alzhcimcr's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer' s disease [ J ]. Neurology, 1984, 34(7) : 939-944.
  • 9Dubois B, Feldman HH, Jaeova C, et al. Research criteria for the diagnosis of Alzheimer's disease: revising the NINCDS-ADR- DA criteria[J]. Lancet Neurol, 2007, 6(8) : 734-746.
  • 10Dubois B, Feldman HH, Jacova C, et al. Revising the definition of Alzheimer' s disease : a new lexicon [ J ]. Lancet Neurol, 2010, 9(11) : 1118-1127.

共引文献54

同被引文献25

引证文献4

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部